This inventor holds 1 USPTO granted patent. Top assignee: Lpb Istituto Farmaceutico. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: The Innovations of Gabriele Braglia in Pharmaceutical Treatments
Introduction
Gabriele Braglia is a notable inventor based in Carimate, Italy. With a focus on improving the quality of life for the elderly, he has dedicated his efforts to developing innovative treatments for brain-related conditions.
Latest Patents
Gabriele Braglia holds a patent for a breakthrough pharmaceutical composition designed for the treatment of involutional brain syndromes and mental decay. This patent focuses on the use of L-alpha-glycerylphosphorylcholine, a compound that has shown effectiveness in addressing brain involutional syndromes of essential, vascular, or traumatic origins, particularly benefiting the elderly population.
Career Highlights
Braglia's work has been recognized in the pharmaceutical field, particularly due to his dedication to addressing mental decay. He is associated with Lpb Istituto Farmaceutico S.p.a., where he leverages his expertise to advance therapeutic options for patients suffering from cognitive decline.
Collaborations
In his professional journey, Gabriele has collaborated with Carlo Scolastico, contributing to the shared goal of enhancing treatment strategies in the pharmaceutical industry. Their combined efforts focus on innovation and improving outcomes for patients.
Conclusion
Gabriele Braglia's innovative contributions to the field of pharmaceuticals, particularly concerning brain health, are commendable. His patent illustrates his commitment to finding solutions for the challenges faced by the elderly, making him a significant figure in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile